NFKB1 and early-onset autosomal dominant Alzheimer disease: Previous studies have shown that the abnormal regulation of the NF-κB pathway in microglia is involved in the development of pathological conditions such as ischemia, Alzheimer’s disease, and autoimmune encephalomyelitis [37].